Hutch News

Hutch News

Stories tagged 't cell therapy'

Dr. Carl June weaves together HIV and cancer research to advance cures for both

CAR T-cell pioneer and one-time bone marrow transplant fellow will give keynote at HIV cure conference

Aug. 17, 2017 | By Mary Engel / Fred Hutch News Service

Being in two camps — HIV and cancer research — at one time "made a huge, huge impact on me," says immunotherapy researcher Dr. Carl June.

View story >


How cancer fools healthy neighboring cells

‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients

July 18, 2017 | By Rachel Tompa / Fred Hutch News Service

Like tiny con men, cancer cells have many tricks to fool healthy cells into helping them. Research into the "tumor microenvironment" is uncovering new avenues for treatment.

View story >


Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma

May 31, 2017 | By Rachel Tompa / Fred Hutch News Service

In a small, ongoing clinical trial testing a combination of three therapies, three of four patients with advanced Merkel cell carcinoma went into complete remission.

View story >


When do we say cure?

A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics

July 8, 2016 | By Rachel Tompa / Fred Hutch News Service

An individual patient may not hear the word "cure" on their oncologist's lips, but that doesn't mean the word has no meaning to researchers. It's just that it's very difficult to apply it to an individual person.

View story >


Seattle's life sciences scene in the spotlight

Xconomy forum highlights research in vaccines, organ transplants, big data, more

May 3, 2016 | By Rachel Tompa / Fred Hutch News Service

It was a dizzying round-up of Seattle’s life sciences research and biotech scene, from designer proteins to the looming threat of the Zika virus. This year’s forum was titled “Life Sciences Disruptors,” though Lash and the other speakers didn’t focus on the technology buzzword theme, but if there was one common thread to the afternoon’s whirlwind tour of Seattle’s public and private life sciences work it was that which is new and unexpected — and a look to the future of healthcare.

View story >


Crafting a better T cell for immunotherapy

New technology, not yet tested in humans, aims to reduce patients’ waiting time, increase potency of T-cell therapy

Feb. 22, 2016 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch immunotherapy researchers Drs. Stan Riddell and Steven Liu have collaborated with others to devise a new approach to T-cell therapy that could both speed up and boost the effectiveness of the experimental new treatment.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.